Lower Risk cannabis use Guidelines for Canada (LRCUG): A narrative review of evidence and recommendations

Canadian Journal of Public Health

Volumn 102, Issue 5, 2011, Pages 324-327

  Fischer, Benedikt ^a,b   Jeffries, Victoria ^a   Hall, Wayne ^c   Room, Robin ^d,e   Goldner, Elliot ^a   Rehm, Jürgen ^b,f  

^a SIMON FRASER UNIVERSITY   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canada; Cannabis; Epidemiology; Morbidity; Policy; Public health

Indexed keywords

EID: 80053551773     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404169     Document Type: Review

References (50)

1. Health Canada. Canadian Alcohol and Drug Use Monitoring Survey, 2010.
2. Room R, Fischer B, Hall W, Lenton S, Reuter P. Cannabis Policy: Moving Beyond Stalemate. New York, NY: Oxford University Press and The Beckley Foundation, 2010.
3. Dauvergne M. Trends in police-reported drug offences in Canada. Juristat 2009;29:1-25.
4. Room R, Babor T, Rehm J. Alcohol and public health: A review. Lancet 2005;365:519-30.
5. Fischer B, Rehm J, Irving H, Ialomiteanu A, Fallu J-S, Patra J. Typologies of cannabis users and associated characteristics relevant for public health: A latent class analysis of data from a nationally representative Canadian adult survey. Int J Methods Psychiatric Res 2010;19:110-24.
6. Angus Reid Strategies. Canadians want federal government to retain drug harm reduction programs, 2008.
7. Bondy SJ, Rehm J, Ashley MJ, Walsh G, Single E, Room R. Low-risk drinking guidelines: The scientific evidence. Can J Public Health 1999;90:264-70.
8. Lynskey MT, Coffey C, Degenhardt L, Carlin JB, Patton G. A longitudinal study of the effects of adolescent cannabis use on high school completion. Addiction 2003;98:685-92.
9. Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addiction 2008;103:969-76.
10. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;374:1383-91.
11. Anthony J. The epidemiology of cannabis dependence. In: Roffman R, Stephens R (Eds.), Cannabis Dependence: Its Nature, Consequences and Treatment. Cambridge, UK: Cambridge University Press, 2006.
12. Kalant H. Adverse effects of cannabis on health: An update of the literature since 1996. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004;28:849-63.
13. Fergusson DM, Horwood LJ, Ridder EM. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005;100:354-66.
14. Rey JM, Sawyer MG, Raphael B, Patton GC, Lynskey MT. Mental health of teenagers who use cannabis: Results of an Australian survey. Br J Psychiatry 2002;180:216-21.
15. McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W. Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies. Int J Drug Policy 2010;21:10-19.
16. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005;57:1117-27.
17. Hall WD, Lynskey M. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev 2005;24:39-48.
18. Patton GC, Coffey C, Lynskey MT, Reid S, Hemphill S, Carlin JB, et al. Trajectories of adolescent alcohol and cannabis use into young adulthood. Addiction 2007;102:607-15.
19. Kelly E, Darke S, Ross J. A review of drug use and driving: Epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev 2004;23:319-44.
20. Coffey C, Carlin JB, Degenhardt L, Lynskey M, Sanci L, Patton GC. Cannabis dependence in young adults: An Australian population study. Addiction 2002;97:187-94.
21. Block RI, O'Leary DS, Hichwa RD, Augustinack JC, Boles Ponto LL, Ghoneim MM, et al. Effects of frequent marijuana use on memory related regional cerebral blood flow. Pharmacology, Biochemistry & Behavior 2002;72:237-50.
22. Pope HG, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996;275:521-27.
23. Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004;99:1333-41.
24. Andreasson S, Allebeck P, Rydberg U. Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand 1989;79:505-10.
25. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003;33:15-21.
26. Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 2007;370:319-28.
27. Fergusson DM, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997;92:279-96.
28. Henquet C, Krabbendam L, de Graaf R, ten Have M, van Os J. Cannabis use and expression of mania in the general population. J Affect Disord 2006;95:103-10.
29. Andreasson S, Allebeck P. Cannabis and mortality among young men: A longitudinal study of Swedish conscripts. Scand J Soc Med 1990;18:9-15.
30. Health Canada. Canadian Alcohol and Drug Use Monitoring Survey (CADUMS): Summary Results for 2008. Ottawa, ON: Health Canada, 2009. Available at: www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2008/summary-sommaire-eng.php (Accessed March 2, 2010).
31. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications. Arch Intern Med 2007;167:221-28.
32. Hashibe M, Straif K, Tashkin DP, Morgenstern H, Greenland S, Zhang ZF. Epidemiologic review of marijuana use and cancer risk: A systematic review. Alcohol 2005;35:265-75.
33. Swift W, Copeland J, Lenton S. Cannabis and harm reduction. Drug Alcohol Rev 2000;19:101-12.
34. Tashkin DP. Effects of cannabis on the respiratory system. In: Kalant H, Corrigall W, Hall W, Smart R (Eds.), The Health Effects of Cannabis. Toronto, ON: Addiction Research Foundation, 1999.
35. Hazekamp A, Ruhaak R, Zuurman L, van Gerven J, Verpoorte R. Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. J Pharm Sci 2006;95:1308-17.
36. Gieringer D, St. Laurent J, Goodrich S. Cannabis vaporizer combines efficient delivery of THC with effective suppression of pryolytic compounds. J Cannabis Therapeutics 2004;4:7-27.
37. King LA, Carpentier C, Griffiths P. Cannabis potency in Europe. Addiction 2005;100:884-86.
38. Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, et al. Highpotency cannabis and the risk of psychosis. Br J Psychiatry 2009;195:488-91.
39. Porath-Waller AJ, Beirness DJ, Beasley EE. Toward a more parsimonious approach to drug recognition expert evaluations. Traffic Inj Prev 2009;10:513-18.
40. Ramaekers JG, Bergaus G, van Laar M, Drummer OH. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 2004;73:109-19.
41. Fergusson DM, Horwood LJ, Boden JM. Is driving under the influence of cannabis becoming a greater risk to driver safety than drink driving? Findings from a longitudinal study. Accid Anal Prev 2008;40:1345-50.
42. Sewell RA, Poling J, Sofuoglu M. The effect of cannabis compared with alcohol on driving. Am J Addict 2009;18:185-93.
43. Grotenhermen F, Leson G, Berghaus G, Drummer OH, Kruger H, Longo M, et al. Developing limits for driving under cannabis. Addiction 2007;102:1910-17.
44. Ramaekers J, Berghaus G, van Laar M, Drummer O. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 2004;73:109-19.
45. El Marroun H, Tiemeier H, Steegers EAP, Jaddoe VWV, Hofman A, Verhulst FC, et al. Intrauterine cannabis exposure affects fetal growth trajectories: The Generation R Study. J Am Acad Child Adolesc Psychiatry 2009;48:1173-81.
46. Schempf AH. Illicit drug use and neonatal outcomes: A critical review. Obstet Gynecol Surv 2007;62:749-57.
47. Fergusson DM, Horwood LJ, Northstone K, ALSPAC Study Team. Maternal use of cannabis and pregnancy outcome. BJOG: Int J Obstetrics Gynaecol 2002;109:21-27.
48. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation 2001;103:2805-9.
49. Degenhardt L, Hall W, Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 2003;71:37-48.
50. van Os J, Bak M, Hanssen M, Bijl R, de Graaf R, Verdoux H. Cannabis use and psychosis: A longitudinal population-based study. Am J Epidemiol 2002;156:319-27.